Urban Szymon, Fułek Michał, Błaziak Mikołaj, Iwanek Gracjan, Jura Maksym, Fułek Katarzyna, Guzik Mateusz, Garus Mateusz, Gajewski Piotr, Lewandowski Łukasz, Biegus Jan, Ponikowski Piotr, Trzeciak Przemysław, Tycińska Agnieszka, Zymliński Robert
Institute of Heart Diseases, Wroclaw Medical University, 50-376 Wroclaw, Poland.
Department of Internal Medicine, Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, 50-376 Wroclaw, Poland.
J Clin Med. 2022 Sep 21;11(19):5519. doi: 10.3390/jcm11195519.
Despite the progress of its management, COVID-19 maintains an ominous condition which constitutes a threat, especially for the susceptible population. The cardiac injury occurs in approximately 30% of COVID-19 infections and is associated with a worse prognosis. The clinical presentation of cardiac involvement can be COVID-19-related myocarditis. Our review aims to summarise current evidence about that complication. The research was registered at PROSPERO (CRD42022338397). We performed a systematic analysis using five different databases, including i.a. MEDLINE. Further, the backward snowballing technique was applied to identify additional papers. Inclusion criteria were: full-text articles in English presenting cases of COVID-19-related myocarditis diagnosed by the ESC criteria and patients over 18 years old. The myocarditis had to occur after the COVID-19 infection, not vaccination. Initially, 1588 papers were screened from the database search, and 1037 papers were revealed in the backward snowballing process. Eventually, 59 articles were included. Data about patients' sex, age, ethnicity, COVID-19 confirmation technique and vaccination status, reported symptoms, physical condition, laboratory and radiological findings, applied treatment and patient outcome were investigated and summarised. COVID-19-related myocarditis is associated with the risk of sudden worsening of patients' clinical status, thus, knowledge about its clinical presentation is essential for healthcare workers.
尽管在其管理方面取得了进展,但新冠病毒病(COVID-19)仍处于一种不祥的状态,构成了威胁,尤其是对易感人群。心脏损伤发生在约30%的COVID-19感染病例中,并与更差的预后相关。心脏受累的临床表现可能是COVID-19相关心肌炎。我们的综述旨在总结关于该并发症的当前证据。该研究已在国际前瞻性系统评价注册库(PROSPERO,注册号:CRD42022338397)登记。我们使用五个不同的数据库进行了系统分析,其中包括MEDLINE等。此外,还应用了逆向滚雪球技术来识别其他论文。纳入标准为:以英文发表的全文文章,呈现根据欧洲心脏病学会(ESC)标准诊断的COVID-19相关心肌炎病例,且患者年龄超过18岁。心肌炎必须发生在COVID-19感染之后,而非疫苗接种之后。最初,从数据库检索中筛选出1588篇论文,在逆向滚雪球过程中又发现了1037篇论文。最终,纳入了59篇文章。对患者的性别、年龄、种族、COVID-19确诊技术和疫苗接种状况、报告的症状、身体状况、实验室和影像学检查结果、应用的治疗方法以及患者结局等数据进行了调查和总结。COVID-19相关心肌炎与患者临床状况突然恶化的风险相关,因此,了解其临床表现对医护人员至关重要。